Acumapimod

DB15448InvestigationalSmall molecule

Acumapimod is under investigation in clinical trial NCT02926326 (The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers).

Mechanism: Pharmacologically active on Mitogen-activated protein kinase 14
Curator reviewed
Formula / weight: C₂₂H₁₉N₅O₂ · 385.427 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyVGUSQKZDZHAAEE-UHFFFAOYSA-NSMILESCC1=CC=C(C=C1N1N=CC(C(=O)C2=CC=CC(=C2)C#N)=C1N)C(=O)NC1CC1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Acumapimod, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.